VijayKGunugantiMD

Oncology • San Antonio, TX

Gastrointestinal Cancer, Genitourinary Oncology, Hematologic Oncology, Melanoma

CANCER CARE CENTERS OF SOUTH TEXAS

Join to view full profile

Dr. Gunuganti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gunuganti's full profile

Already have an account?

Office
18707 Hardy Oak Blvd
Suite 320
San Antonio, TX 78258
Phone+1 210-545-6972

Fax+1 210-545-1016

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2002 - 2004
Marshfield ClinicResidency, Internal Medicine, 1999 - 2002
Temple University HospitalInternship, Transitional Year, 1998 - 1999
Osmania Medical College NTR UHSClass of 1995
Deccan College of Medical Sciences NTRClass of 1995

Certifications & Licensure

TX State Medical License 2005 - 2025
WI State Medical License 2000 - 2011

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Publications & Presentations

PubMed

16 citations
Safety and Efficacy of Nivolumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.
Joshua J McFarlane, Mark D Kochenderfer, Mark R Olsen, Todd M Bauer, Ana Molina
Clinical Genitourinary Cancer. 2020-12-01
43 citations
Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.
Nicholas J Vogelzang, Mark R Olsen, Joshua J McFarlane, Edward Arrowsmith, Todd M Bauer
Clinical Genitourinary Cancer. 2020-12-01
105 citations
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153.
David M. Waterhouse, Edward B. Garon, Jason C. Chandler, Michael McCleod, Maen A. Hussein
Journal of Clinical Oncology. 2020-09-10

Other Languages

Spanish, Hindi, Telugu, Urdu